Prior to his appointment at TAP, David Newble, a graduate chartered accountant, spent eight years with BTG, a life science technology development company.
The Automation Partnership, a manufacturer of innovative industrial automation for life science research applications, reports the appointment of David Newble as its new chief financial officer.
Here he gained extensive experience in financial management and fund raising for both public and private companies; as well as in creating and developing technology based companies.
Newble also brings substantial knowledge of the US technology market having spent four years working in BTG's US subsidiary as finance director and latterly as general manager where he was instrumental in supporting the growth of the firm's business there.
For the past two years, Newble has been group finance director at BTG where he assessed and managed the finances and risks associated with many major life science development programmes.
During this time, Newble also worked closely with the new CEO as part of a team responsible for a major strategy review, which resulted in the subsequent transformation of BTG into a profitable, medical innovations company.
Commenting on his new position, David Newble said: "I am very pleased to be coming to TAP as it is a great opportunity to be part of one of the UK's leading specialist technology companies.
"TAP has a compelling mix of systems and software for the pharma industry and is backed by an exceptionally talented team and I hope my expertise will help TAP to focus on making the necessary changes required to set and realise key strategic milestones".
Andy Morffew, CEO at TAP, added: "We are delighted that David Newble has agreed to join our new executive team.
"His experience in devising strategy and managing change will be invaluable going forward.
"This coupled with his business and financial acumen will I believe contribute in TAP's commercial success."
